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Abstract
Background: Understanding the factors that influence the hospital length of stay (LOS) for patients with stroke will
help in discharge planning and stroke unit management. We explored how intravenous thrombolysis (IVT) affects
LOS in an acute-care hospital setting.
Methods: We analyzed adult patients with ischemic stroke who presented within 48 h of onset from a hospital-based
stroke registry. The relationship between IVT and prolonged LOS (LOS≥ 7 days) was studied by both multivariate
logistic regression and the classification and regression tree (CART) analyses.
Results: Among the study population of 3054 patients, 1110 presented within 4.5 h. The median LOS (interquartile
range) was 7 (4 to 11) days, and 1619 patients had prolonged LOS. Multivariate logistic regression revealed that IVT
(odds ratio, 0.53; 95 % confidence interval 0.38–0.74) was an independent factor that reduced the risk of prolonged
LOS, whereas age, National Institutes of Health Stroke Scale (NIHSS) score, diabetes mellitus, and leukocytosis at
admission predicted prolonged LOS. CART analysis identified 4 variables (NIHSS score, IVT, leukocytosis at admission,
and age) as important factors to partition the patients into six subgroups. The patient subgroup that had an NIHSS
score of 5 to 7 and received IVT had the lowest probability (19 %) of prolonged LOS.
Conclusions: IVT reduced the risk of prolonged LOS in patients with acute ischemic stroke. Measures to increase the
rate of IVT are encouraged.
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Background
Stroke has been one of the three leading causes of mor-
tality since the1960s in Taiwan [1]. In addition, it is an
important cause of disability in adults, particularly
among the elderly population, and it imposes a huge
burden on health care resources [2, 3]. Its global disease
burden increased from fourth in 2001 to third in 2010
[4, 5]. In Taiwan, the stroke-associated disease burden
increased each year from 2000 to 2005 and is expected
to further increase in the future [6]. Therefore, the
health care costs for stroke will inevitably rise. With the
continuing growth of health care costs, a hospital global
budgeting system has been adopted since July 2002 by
the Taiwan National Health Insurance (NHI) to control
medical expenditures. Consequently, the overall hospital
net revenues have reduced and hospitals are under in-
creased financial stress [7].
The hospital length of stay (LOS) for patients with
stroke has been found to be closely correlated with
medical costs [2, 8–10]. A better understanding of the
factors that influence LOS would not only facilitate dis-
charge planning and help control medical costs but also
have implications for the management of stroke units.
LOS is a widely used quality measure that is incorpo-
rated in Taiwan’s nationwide health care quality indica-
tor system [11]. Several factors have been identified as
significant predictors of prolonged LOS for patients with
stroke, including initial stroke severity, stroke subtype,
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leukocytosis at admission, prestroke disability, diabetes
mellitus, congestive heart failure, atrial fibrillation, cor-
onary heart disease, chronic obstructive pulmonary dis-
ease, and hyperlipemia [9, 12–16]. Validated tools are
also available to predict prolonged LOS in the acute
stroke setting [14, 17–19].
Intravenous thrombolysis (IVT) with tissue-type plas-
minogen activator (tPA) is currently the standard treat-
ment for acute ischemic stroke. It significantly reduces
the proportion of patients who were dead or dependent
at 3 to 6 months after the stroke [20]. However, few re-
ports have investigated the relationship of IVT and LOS.
One study showed that among patients treated with
IVT, the independent variables that affected LOS include
a lack of improvement at 24 h after treatment, cortical
involvement, and the presence of new infarction on the
24-h computed tomography scans [13]. Data from ran-
domized trials showed significantly shorter LOS in tPA-
treated patients than in control patients [21, 22]. However,
whether IVT impacts LOS in patients with acute ischemic
stroke in daily practice remained unclear. Therefore, we
conducted this study to examine how IVT affects LOS in
an acute-care hospital setting using both conventional
statistical methods and data mining techniques.
Methods
Patients
We analyzed data from a hospital-based stroke registry,
which prospectively registered all patients with stroke
who were admitted to the Ditmanson Medical Foundation
Chia-Yi Christian Hospital according to the design of the
nationwide Taiwan Stroke Registry [23]. The hospital,
which has 1000 beds and is the largest hospital in Chiayi
City, provides health care to approximately one million in-
habitants in the city and its adjoining rural area. The
Chia-Yi Christian Hospital Institutional Review Board
approved the study protocol.
We identified patients with ischemic stroke who were
aged 20 years or older and were admitted within 48 h
of stroke onset between October 2007 and December
2013. Patients with in-hospital stroke and those without
complete data were excluded. Ischemic stroke is de-
fined as the acute onset of neurologic deficits that per-
sist longer than 24 h with no indications of hemorrhage
on the first brain computed tomography or with acute
corresponding ischemic lesion(s) on diffusion-weighted
magnetic resonance imaging. Data on patient character-
istics, including demographic data, medical history, co-
morbidity conditions, treatments, complications, and
outcomes, were obtained from the stroke registry. Stroke
severity was assessed with the National Institutes of
Health Stroke Scale (NIHSS) and stroke mechanism was
determined based on the Trial of ORG 10172 in Acute
Stroke Treatment classification [24]. The functional status
was evaluated at discharge according to the modified
Rankin Scale.
The decision to treat stroke patients with IVT was
generally made according to the guidelines released by
the Taiwan Stroke Society in 2003 [25], which have been
adopted by the Taiwan NHI as the basis of reimburse-
ment for IVT. The major discrepancies between the
guidelines and the American Heart Association guide-
lines [26] are the exclusion of patients with the following
characteristics: older than 80 years, history of previous
stroke and diabetes mellitus, stroke onset more than 3 h,
severe stroke (NIHSS score > 25), and minor stroke (spe-
cifically defined as a stroke with an NIHSS score < 6).
Patients who were not eligible for IVT according to the
Taiwan Stroke Society guidelines but who were indicated
for treatment according to the American Heart Association
guidelines (e.g., age over 80 years, stroke onset between 3
and 4.5 h, minor stroke with an NIHSS score < 6, or severe
stroke with an NIHSS score > 25) were treated if the
physician and the patient agreed and if the patient paid
the cost of tPA on their own.
Definition of the variables
The outcome of interest was prolonged LOS that was di-
chotomized at ≥ 7 days of hospitalization, and this div-
ision conformed to those of previous studies on LOS in
patients with stroke [13, 14]. The study hospital only of-
fers acute-care hospitalization of patients with stroke.
LOS was defined as the time from admission to dis-
charge. The admission date was defined as the date on
which the patient was admitted to the hospital, and the
discharge date was defined as the date on which the pa-
tient died or was discharged to home, another hospital, a
rehabilitation facility, or a nursing home.
The predictor variables were determined a priori on the
basis of previous studies [9, 12–16] and clinical experi-
ence. In addition to the use of IVT, we only evaluated
those factors that could be assessed at the time of admis-
sion. The variables included age, gender, admission NIHSS
score, prior functional dependency (modified Rankin Scale
score ≥ 3), medical conditions (hypertension, diabetes
mellitus, hyperlipidemia, prior stroke, atrial fibrillation,
coronary heart disease, congestive heart failure, malig-
nancy, or uremia on dialysis), smoking status, prior use of
antiplatelet or oral anticoagulant drugs, and leukocytosis
(>10 × 109 cells/L) at admission.
Statistical analysis
The bivariate associations between the baseline charac-
teristics of the patients and prolonged LOS were exam-
ined with appropriate tests (chi-squared test, t-test, or
Mann–Whitney U-test). A multivariate logistic regression
was used to determine the variables independently associ-
ated with prolonged LOS. All the prespecified predictor
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variables were entered into the model. Considering the
nonlinear relationship between the NIHSS score and LOS
[12–14], stroke severity was categorized into the following
5 groups according to the NIHSS score: 0–5, 6–10, 11–15,
16–20, and > 20 [14]. Because of the increased risk of early
mortality in patients with the most severe strokes, a separ-
ate multivariate logistic regression was conducted only on
hospital survivors. The discrimination of the model was
assessed with the area under the receiver operating char-
acteristic curve (AUC), and the model fit was evaluated
with the Hosmer–Lemeshow goodness-of-fit statistic. Be-
cause IVT should be administered within a narrow time
window, we conducted a subgroup analysis of patients
who presented to the hospital within 4.5 h of stroke onset.
Although LOS was dichotomized in the present study, we
conducted additional analyses treating LOS as a continu-
ous variable. Since LOS shows a right skewed distribution,
the natural logarithm of LOS was used as the dependent
variable for the multiple linear regression analyses. General
statistical analyses were performed with Stata 13 (StataCorp
LP, College Station, TX, USA). Two-tailed p values less than
0.05 were considered statistically significant.
To stratify the risk of prolonged LOS, all the variables
of interest were included in classification and regression
tree (CART) analysis for generating a binary decision
tree. The CART algorithm grows a tree from the root by
selecting the best predictor variable, which is the one
with the lowest Gini index value, as an internal node.
The patients are then split into two subgroups on the
basis of the value of the selected variable [27, 28]. The
partitioning process is recursively applied until the stop-
ping criteria are fulfilled or splitting is impossible. A class
label is then assigned to the terminal node (i.e., leaf node)
on the basis of majority voting. After a decision tree is fully
grown, CART analysis conducts a minimal cost-complexity
pruning method to avoid overfitting. We used the simple-
CART module in Weka 3.6.11 open-source data mining
software (www.cs.waikato.ac.nz/ml/weka) to generate a
CART tree. The minimum number of cases in each node
was set to 30 to simplify the tree structure. A 10-fold cross
validation was used to estimate the predictive accuracy and
AUC of the tree model.
Results
After excluding the 105 patients who had in-hospital
stroke and the 92 patients with missing data, 3054 pa-
tients were used in the analysis. The in-hospital mortal-
ity was 3 %. The median LOS (interquartile range) was 7
(4 to 11) days, and the LOS was ≥ 7 days in 1619 (53 %)
patients. Table 1 summarizes the demographic and clin-
ical characteristics of the patients. Compared with the
patients who were hospitalized for less than 7 days,
those with prolonged LOS were older and more likely to
be female, and they had more severe strokes, less strokes
due to small-vessel occlusion, and a higher prevalence of
hypertension, diabetes mellitus, prior stroke, atrial fib-
rillation, coronary heart disease, and congestive heart
failure. In addition, they were prone to be functionally
dependent before admission, have leukocytosis at ad-
mission, be treated with IVT, and have more complica-
tions during the hospitalization. Although the patients
with prolonged LOS had worse functional outcomes at
discharge, their in-hospital mortality rate did not differ
from that of the patients without prolonged LOS.
Table 2 summarizes the results of multivariate logistic
regression analysis. Age, admission NIHSS score, dia-
betes mellitus, and leukocytosis at admission predicted
prolonged LOS, whereas the use of IVT was an inde-
pendent predictor of shorter LOS. Compared with pa-
tients with NIHSS scores ≤ 5, the odds ratio of having
prolonged LOS increased from 2.75 for patients with
NIHSS scores of 6–10 to 8.01 for patients with NIHSS
scores of 11–15 and 9.65 for patients with NIHSS scores
of 16–20 and then decreased to 7.62 for patients with
NIHSS scores > 20. When only hospital survivors were an-
alyzed, the odds ratio increased with increasing NIHSS
scores (Table 2). The model discrimination was acceptable
with AUC of 0.735 (95 % confidence interval [CI],
0.717–0.752) for all the patients and 0.750 (95 % CI,
0.732–0.767) for the hospital survivors. The Hosmer–
Lemeshow goodness-of-fit statistic was not significant
for all the patients (p = 0.782) and the hospital survi-
vors (p = 0.978), indicating adequate fitness. In the sub-
group of patients who presented within 4.5 h of stroke
onset, the use of IVT remained an independent pre-
dictor of shorter LOS (Table 3). In addition, patients
taking oral anticoagulants had a lower chance of pro-
longed LOS. AUC was 0.734 (95 % CI, 0.705–0.764)
for all the patients in the subgroup and 0.765 (95 %
CI, 0.736–0.793) for the hospital survivors, and the
p values for the Hosmer–Lemeshow goodness-of-fit
tests were 0.856 and 0.424, respectively. In the add-
itional multiple linear regression analyses, the use of
IVT was still an independent predictor of shorter LOS
in all study patients (p = 0.012) and in patients pre-
sented within 4.5 h (p = 0.034).
Four variables (admission NIHSS score, use of IVT,
leukocytosis at admission, and age) were identified by
CART analysis as important factors, which were used to
partition the patients into six subgroups (Fig. 1). The
NIHSS score was determined as the best discriminator
between patients with prolonged LOS and those without
it. Patients with an initial NIHSS score ≥ 7.5 had a 78 %
probability of prolonged hospitalization. Interestingly,
for patients with an NIHSS score < 7.5, the next best
predictor was still the NIHSS score. Patients with an
NIHSS score < 4.5 had a 33 % risk of prolonged LOS.
For patients with an NIHSS score ≥ 4.5 and < 7.5 (i.e., 5,
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Table 1 Characteristics of patients by LOS category
Characteristic LOS < 7 days (n = 1435) LOS≥ 7 days (n = 1619) P value
Demographics
Age, mean (SD), y 67.8 (11.9) 70.8 (12.0) < 0.001
Female 538 (37.5) 705 (43.6) 0.001
NIHSS at admission < 0.001
≤ 5 1003 (69.9) 553 (34.2)
6–10 290 (20.2) 421 (26.0)
11–15 49 (3.4) 205 (12.7)
16–20 32 (2.2) 163 (10.1)
> 20 61 (4.3) 277 (17.1)
Median (IQR) 4 (2-6) 8 (4-16) < 0.001
Stroke mechanism < 0.001
Large artery atherosclerosis 252 (17.6) 515 (31.8)
Cardioembolism 127 (8.9) 303 (18.7)
Small-vessel occlusion 717 (50.0) 397 (24.5)
Specific etiology 11 (0.8) 30 (1.9)
Undetermined etiology 328 (22.9) 374 (23.1)
Medical conditions
Hypertension 1133 (79.0) 1328 (82.0) 0.032
Diabetes mellitus 584 (40.7) 750 (46.3) 0.002
Hyperlipidemia 837 (58.3) 883 (54.5) 0.035
Prior stroke 380 (26.5) 547 (33.8) < 0.001
Atrial fibrillation 188 (13.1) 372 (23.0) < 0.001
Coronary heart disease 176 (12.3) 241 (14.9) 0.035
Congestive heart failure 56 (3.9) 118 (7.3) < 0.001
Malignancy 75 (5.2) 111 (6.9) 0.060
Uremia on dialysis 22 (1.5) 36 (2.2) 0.163
Current smoker 369 (25.7) 351 (21.7) 0.009
Dependent (mRS≥ 3) before admission 107 (7.5) 266 (16.4) < 0.001
Prior medication use
Antiplatelet 352 (24.5) 446 (27.6) 0.058
Oral anticoagulant 38 (2.7) 49 (3.0) 0.530
Leukocytosis (> 10 × 109 cells/L) at admission 215 (15.0) 398 (24.6) < 0.001
Intravenous thrombolysis 83 (5.8) 123 (7.6) 0.046
Complications
Pneumonia 16 (1.1) 239 (14.8) < 0.001
Urinary tract infection 35 (2.4) 212 (13.1) < 0.001
Upper gastrointestinal bleeding 22 (1.5) 171 (10.6) < 0.001
Symptomatic intracerebral hemorrhage 4 (0.3) 37 (2.3) < 0.001
mRS≥ 3 at discharge 488 (34.0) 1279 (79) < 0.001
Mortality at discharge 46 (3.2) 45 (2.8) 0.489
Data are numbers (percentage) unless specified otherwise
IQR interquartile range, LOS length of stay, mRS modified Rankin Scale, NIHSS National Institutes of Health Stroke Scale, SD standard deviation
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6, and 7), the use of IVT was the best discriminator in
determining prolonged LOS. The subgroup of patients
who had NIHSS scores of 5 to 7 at admission and who
received IVT had the lowest chance (19 %) of prolonged
LOS. When we restricted the analysis to patients with
an NIHSS score of 6 or 7 to conform to the reimburse-
ment criteria of the Taiwan NHI, 20 % of patients treated
with IVT had prolonged LOS and 54 % of those not
treated had prolonged LOS. The evaluation results of
the 10-fold cross validation showed that the outcomes of
67.4 % of the patients were correctly predicted by the
CART tree, and the estimate of AUC of the tree model
was 0.701.
Discussion
With the use of both logistic regression and CART ana-
lyses, we found that IVT independently predicted a
lower probability of prolonged LOS during acute-care
hospitalization in patients with ischemic stroke who
were admitted within 48 h of stroke onset. In addition,
the use of IVT was the best determinant of prolonged
LOS in patients with an initial NIHSS score of 5 to 7
according to CART analysis. Both analytic methods iden-
tified the initial NIHSS score as the major predictor of
LOS. Other significant factors were age, diabetes melli-
tus, and leukocytosis at admission. Although patients
with the most severe strokes are at an increased risk of
early mortality, the effect of IVT on LOS did not change
materially when only hospital survivors were analyzed.
In the subgroup of patients who presented within 4.5 h,
we identified oral anticoagulant use as an additional
factor that reduced the risk of prolonged LOS. While
preadmission oral anticoagulant treatment in patients
with atrial fibrillation is associated with less severe
strokes [29], understanding its relationship with LOS
requires further investigation.
In agreement with the results of previous randomized
trials [21, 22], our results demonstrated that IVT re-
duced the chance of prolonged LOS in real-world prac-
tice. Moreover, the results showed that patients with
NIHSS scores of 5 to 7 had the lowest probability of
prolonged LOS if they were treated with IVT, even lower
than patients with NIHSS scores < 5. The clinical impli-
cations of these findings are twofold if LOS for stroke is
Table 2 Predictors of prolonged LOS using multivariate logistic regression
OR (95 % CI), all patients, n = 3054 P value OR (95 % CI), hospital survivors, n = 2963 P value
Age 1.01 (1.00–1.02) 0.019 1.01 (1.00–1.02) 0.019
NIHSS at admission
≤ 5 Reference Reference
6–10 2.75 (2.28–3.33) < 0.001 2.83 (2.34–3.43) < 0.001
11–15 8.01 (5.67–11.31) < 0.001 8.32 (5.86–11.83) < 0.001
16–20 9.65 (6.32–14.74) < 0.001 11.07(7.06–17.36) < 0.001
> 20 7.62 (5.48–10.60) < 0.001 19.15 (12.01–30.53) < 0.001
Diabetes mellitus 1.30 (1.10–1.53) 0.002 1.34 (1.13–1.58) 0.001
Leukocytosis (> 10 × 109 cells/L) at admission 1.46 (1.19–1.80) < 0.001 1.55 (1.25–1.92) < 0.001
Intravenous thrombolysis 0.53 (0.38–0.74) < 0.001 0.49 (0.34–0.71) < 0.001
CI confidence interval, LOS length of stay, NIHSS National Institutes of Health Stroke Scale, OR odds ratio
Table 3 Predictors of prolonged LOS in patients presented within 4.5 h using multivariate logistic regression
OR (95 % CI), all patients, n = 1110 P value OR (95 % CI), hospital survivors, n = 1053 P value
NIHSS at admission
≤ 5 Reference Reference
6–10 2.52 (1.80–3.54) < 0.001 2.75 (1.94–3.89) < 0.001
11–15 8.69 (5.02–15.0) < 0.001 9.92 (5.59–17.61) < 0.001
16–20 8.70 (4.80–15.8) < 0.001 10.12 (5.36–19.10) < 0.001
> 20 5.82 (3.69–9.18) < 0.001 16.99 (8.97–32.19) < 0.001
Atrial fibrillation 1.37 (0.95–1.97) 0.087 1.68 (1.12–2.51) 0.011
Oral anticoagulant 0.39 (0.18–0.83) 0.015 0.30 (0.13–0.69) 0.005
Leukocytosis (> 10 × 109 cells/L) at admission 1.50 (1.07–2.11) 0.020 1.59 (1.10–2.29) 0.013
Intravenous thrombolysis 0.48 (0.33–0.71) < 0.001 0.42 (0.27–0.64) < 0.001
CI confidence interval, LOS length of stay, NIHSS National Institutes of Health Stroke Scale, OR odds ratio
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to be shortened. First, because IVT is only indicated
for patients presenting within a narrow time window,
it is crucial for health care providers to promote pub-
lic awareness of the benefits of prompt stroke treat-
ment. A study has shown that educating patients to
seek treatment sooner needs to be a major element
of system-wide interventions that are designed to in-
crease the use of thrombolysis treatment in patients
with acute ischemic stroke [30]. In Taiwan, the prolonged
time interval between the onset of stroke symptoms and
the decision to seek medical help is the underlying cause
of delayed hospital presentation, particularly in older pa-
tients and those with mild stroke [31]. Therefore, public
education programs should be targeted to the older popu-
lation and should emphasize on the recognition of early
stroke symptoms. Second, because IVT is not reimbursed
by the Taiwan NHI in patients with NIHSS scores < 6, it is
prudent for the Taiwan NHI administration to reconsider
its coverage policy for IVT.
Our findings were in line with those of earlier studies
[12–14] that indicated the important role of the initial
NIHSS score in determining LOS and the nonlinear
relationship between the NIHSS score and LOS. In our
study, increasing NIHSS scores initially increased the
chance of prolonged LOS, which then peaked between
NIHSS scores of 16 and 20 and then declined, while the
risk of prolonged LOS in the hospital survivors was
associated with increasing NIHSS scores. In addition,
CART analysis automatically determined the optimal
cut-off points of NIHSS scores that can be used to guide
the need for intervention when assessing a patient’s risk
of prolonged LOS. The ability to decide cut-off points is
one of the main advantages of decision tree-based
methods [32]. In addition, decision tree-based methods
facilitate the identification and interpretation of complex
interactions among predictor variables [32, 33]. For ex-
ample, the benefit of IVT, in terms of reducing the risk
of prolonged LOS, could hardly be identified in patients
with NIHSS scores of 5 to 7 in logistic regression analysis.
It is generally agreed that LOS is the main cost-
determining factor in patients with acute stroke [2, 8–10].
However, shortened LOS cannot be necessarily translated
to a reduction in acute-care hospital costs for patients
treated with IVT because of the extra cost that is incurred
by administering tPA. Nevertheless, because IVT signifi-
cantly reduces the probability of patients being functionally
dependent after stroke [20] and level of physical disability
and level of neurological deficit determine direct healthcare
costs within 1 year [34], the financial benefits of IVT are
mainly related to the decreased costs in long-term hospital
and community care [35]. A systematic review found that
IVT was associated with an acceptable rise in short-term
costs in the management of patients with acute ischemic
stroke and it was cost saving in the long run [36]. Even
without reducing the acute-care hospital costs, the reduced
incidence of prolonged LOS as a result of IVT is still mean-
ingful with regard to the allocation of health care resources.
With the rapid growth in the elderly population in Taiwan
[37], the incidence of stroke will substantially increase and
the need for acute stroke care will grow. Shortening acute-
care LOS might help relieve the demand for stroke unit
beds and neurologists dedicated to stroke care. In particu-
lar, a growing shortage of vascular neurologists is antici-
pated [38].
The limitations of our study are as follows: First, this
is a single-hospital study, and generalizations should
therefore be made with caution. Second, given the retro-
spective nature of the study and the use of register data,
not all variables that may influence LOS were available
for analysis. For instance, we did not explore IVT-related
variables such as rapid improvement after thrombolysis,
Fig. 1 Risk stratification for prolonged LOS by means of the classification
and regression tree analysis. Abbreviations: IV, intravenous; LOS, length of
stay; NIHSS, National Institutes of Health Stroke Scale
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new infarction, and cortical involvement on follow-up
neuroimaging, which have been shown to independently
affect LOS [13]. Third, we did not investigate in-hospital
neurological or medical complications, which are associ-
ated with longer LOS [39]. We evaluated only those fac-
tors that could be assessed at the time of admission
because tPA should be administered shortly after patient
arrival at the hospital.
Conclusions
IVT decreased the risk of prolonged LOS in patients
with acute ischemic stroke regardless of inital stroke se-
verity. Shortening acute-care LOS could help reduce the
demand for stroke unit beds and thus improve health
care resource allocation. Measures to increase the use of
IVT, including public education for stroke awareness
and modification of reimbursement criteria for IVT in
patients with acute ischemic stroke, are encouraged.
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